Issue 12, 2016

A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease and is still incurable. Traditional therapies use diagnostic and therapeutic drugs separately, which is unfavourable for exploring the pathology of AD and optimizing the efficacy of drugs. Theranostic agents that combine diagnosis and targeted therapy could overcome the weakness of current approaches through the complementary action between the two functions. Owing to the intense relevance to AD pathogenesis, metal-associated amyloid-β (Aβ) species have been considered as the primary targets for anti-AD. We herein report a fluorescent chelator (BTTA) as a potential theranostic agent for both attenuating and fluorescence imaging of Cu2+-induced Aβ aggregation in the AD brain. Considerable evidence shows that BTTA is able to specifically target Cu2+-associated Aβ aggregates and capture Cu2+ ions to attenuate the aggregates and their neurotoxicity. Most notably, the disaggregation of Cu2+–Aβ aggregates can be monitored by the fluorescence changes of BTTA from both buffer and brain homogenates of AD mice. Moreover, BTTA can also be used to visually detect the Aβ aggregates via fluorescence imaging of slices of brain tissues from AD mice and is verified to penetrate the blood brain barrier of mice in vivo. These findings suggest that BTTA would provide a promising strategy to develop potential theranostic tools for AD.

Graphical abstract: A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease

Supplementary files

Article information

Article type
Research Article
Submitted
23 Jul 2016
Accepted
01 Oct 2016
First published
07 Oct 2016

Inorg. Chem. Front., 2016,3, 1572-1581

A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease

T. Yang, L. Yang, C. Zhang, Y. Wang, X. Ma, K. Wang, J. Luo, C. Yao, X. Wang and X. Wang, Inorg. Chem. Front., 2016, 3, 1572 DOI: 10.1039/C6QI00268D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements